|
|||||||||||||||||
|
EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation | Submit Manuscript
Volume 10, Number 8, August 2004 Antimicrobial Drug Use and Methicillin-resistant Staphylococcus aureus, Aberdeen, 1996–2000Dominique L. Monnet,* Fiona M. MacKenzie,† José María López-Lozano,‡
Arielle Beyaert,§ Máximo Camacho,§ Rachel Wilson,† David Stuart,† and
Ian M. Gould† |
||
|
Back to article | |
Figure 3. Evolution of the monthly % methicillin-resistant Staphylococcus aureus (MRSA) and monthly sum of lagged antimicrobial use as identified in polynomial distributed lag (PDL) model: macrolides (lags of 1 to 3 months), third-generation cephalosporins (lags of 4 to 7 months), and fluoroquinolones (lags of 4 and 5 months), Aberdeen Royal Infirmary, January 1996–December 2000. |
|
|
|
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
|
This page last reviewed July 22, 2004 |
|
Emerging
Infectious Diseases Journal |
|